Structural Modeling of New Polymorphism Clusters of HCV Polymerase Isolated from Direct‐Acting Antiviral Naïve Patients: Focus on Dasabuvir and Setrobuvir Binding Affinity-Reference-Cited by-同舟云学术

Structural Modeling of New Polymorphism Clusters of HCV Polymerase Isolated from Direct‐Acting Antiviral Naïve Patients: Focus on Dasabuvir and Setrobuvir Binding Affinity

Published:2018-06-04 Issue:21 Volume:3 Page:6009-6017
ISSN:2365-6549
Container-title:ChemistrySelect
language:en
Short-container-title:ChemistrySelect

Author:

Romeo Isabella¹,Marascio Nadia²,Pavia Grazia²,Talarico Carmine¹,Costa Giosuè¹,Alcaro Stefano¹,Artese Anna¹^ORCID,Torti Carlo³,Liberto Maria Carla²,Focà Alfredo²

Affiliation:

1. Department of Health SciencesUniversity “Magna Graecia” of Catanzaro, Viale Europa, Germaneto 88100 Catanzaro Italy

2. Department of Health SciencesInstitute of MicrobiologySchool of MedicineUniversity “Magna Graecia” of Catanzaro, Viale Europa, Germaneto 88100 Catanzaro Italy

3. Department of Medical and Surgical SciencesUnit of Infectious and Tropical DiseasesSchool of MedicineUniversity “Magna Graecia” of Catanzaro, Viale Europa, Germaneto 88100 Catanzaro Italy).

Funder

University “Magna Graecia” of Catanzaro

Publisher

Wiley

Subject

General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/slct.201800649

Reference34 articles.

1. EASL Recommendations on Treatment of Hepatitis C 2016

2. Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials

3. Speeding up Early Drug Discovery in Antiviral Research: A Fragment-Based in Silico Approach for the Design of Virtual Anti-Hepatitis C Leads